1 / 13

Engineering Gut Microbiota

Engineering Gut Microbiota. Fei Chen 5/11/08. The Big Picture. Gut microbiota provide a dynamic and very beneficial symbiotic relationship with human hosts. Gut microbiota perform key functions in metabolism They influence drug response, and the development of many diseases.

Télécharger la présentation

Engineering Gut Microbiota

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Engineering Gut Microbiota Fei Chen 5/11/08

  2. The Big Picture • Gut microbiota provide a dynamic and very beneficial symbiotic relationship with human hosts. • Gut microbiota perform key functions in metabolism • They influence drug response, and the development of many diseases. • Genetically engineered gut bacteria can have far-ranging impact on health and quality of life.

  3. Some Background • Present in immense numbers of in the gut:~1 x 1014 bacteria. • 30-40 species compose of 99% of the population. • Mutualistic/symbiotic relationship with hosts. In humans, they serve several key roles: • Metabolism and fermenting unused energy substrates. • Training the immune system • Production of vitamins. • And competitive inhibition of harmful species. • Very significant for health: • Obesity • Disease • Aging • ‘Gut’ refers to the general digestive tract, in terms of microflora, we are interested in the large intestine, especially the Cecum, where a large population of bacteria is present.

  4. The Question Posed Is: • How can we engineer bacteria as to make a superior gut microbe?

  5. Is It Viable? Some Considerations… • Gut flora maintains a dynamic relationship with the host immune-system. The introduced engineered bacteria must not promote a immune-response from the host. • Research has already shown that a specific strain of E. Coli, NISSLE 1917, can be engineered and introduced to the mice gut without provoking an immune response. • Gut flora is very sensitive to environmental changes. Small changes in pH or population can cause drastic changes to population make-up. • We have to consider the interaction between our genetically engineered flora and the local microbes.

  6. Possible Ideas • There are many possible applications in engineering gut microbes. Five projects based on these ideas are: • Gut pH management • Vitamin Production • Lactase Production/Digestion • Pathogenic Defense • Varied expression through Slipped Strand Mismatching

  7. Gut pH Maintenance • The flora in the gut is very sensitive to pH. • The body maintains a healthy bacterial ecosystem using pH. Our bacteria could do the same. • The pH of an healthy adult Cecum is around 6.4. (std. dev. 0.4) • Design a system which maintains the pH in this range. • System Requirements: • Sense and respond to external pH. • Create byproducts which buffers external pH. • Reducing pH would be easy, acids are byproducts of metabolism. • Increasing pH is harder.

  8. Vitamin Production • Bacteria are responsible for the production of several vitamins required for the body. Example: E. Coli produces vitamin K. • Engineer bacteria which produce other Vitamins and nutritional benefits. • One example: Beta-Carotene. • Lycopenecyclase, an enzyme separated from cyanobacteria which produces Beta-Carotene from lycopene. • Lycopene is commonly found in human diet, a source is tomatoes. • Design Goal: Engineer bacteria which can produce Beta-Carotene/ Vitamins.

  9. Lactase Production and Dietary Regulation • Lactose is a sugar predominantly found in milk. Lactose intolerance is the inability to metabolize glucose, and is found in a large percentage of Asians and Africans. It is estimated that 70% of adults are lactose intolerant. • Lactase is a glycoside hydrolase which breaks lactose disaccharides into galactose and glucose monomers. • This gene can be incorporated into our engineered bacteria to metabolize lactose in those who have lactose intolerance. • Further ideas in this subsystem include dietary regulation. • Bacteria has been shown to have a significant link with obesity. The cause of this is due to the balance between various subpopulations inhabiting the gut. (How to exploit this is unclear)

  10. Fend Off Pathogens • Example Pathogen: Salmonella (S. Typhimurium ) • One of the major causes of food poisoning. Found in inadequately cooked eggs, pets. • Release of lysogenic phage held in our engineered bacteria to infect and lyse salmonella. • P22 is an well documented phage which infects Salmonella, and has lysogenic/lytic life-cyles. Can enter lytic life cycle after UV-exposure/DNA damage.

  11. Overall System Construction • Use of Slipped-Strand-Mismatching to generate different subpopulations with varied expression. • Possible Ways to Utilize the Idea: • Combinations of Slip-Strand Mismatching devices to create many different phenotypes. We have multiple functions needed by the cell. • Set one phenotype to be more predominant than others. (Example: Set Vitamin production to be the primary phenotype)

  12. Pros and Cons • Many different subsystems which can be constructed because gut microbiota do so much. • Bacteria already inhabit the gut, including as our favorite, E. Coli. • Many of the subsystems are very interesting by themselves and could be very useful for future teams: • Bacterial Phage Production • Slipped-Strand Mismatching for multiple subpopulations. • External pH buffering • The flora of the gut is very complicated and very sensitive. • A lot of work required for each subsection.

  13. References: • Controlling the metabolic flux through the carotenoid pathway using directed mRNA processing and stabilization. C D Smolke, V J Martin, and J D KeaslingMetab Eng. 2001 October; 3(4): 313–321. • Microbial ecology: Human gut microbes associated with obesity Ruth E. Ley, Peter J. TurnbaughNature444, 1022-1023. • Measurement of gastrointestinal pH profiles in normal ambulant human subjects. D F Evans, G Pye, R Bramley, A G Clark, T J Dyson, and J D HardcastleGut. 1988 August; 29(8): 1035–1041. • Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules Astrid M.Westendorf, FlorianGunzer, Stefanie Deppenmeier FEMS Immunol Med Microbiol 2005 Mar 1; 43(3) 373-84.

More Related